← Evidence map

ArticleTransfusion2026

How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?

Leisa Bruneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42762172